the comparison of health-related quality of life between patients with lumbar spinal stenosis (LSS) and healthy controls, while accounting for depression. The authors address a relevant topic as the prevalence of LSS in the elderly is rising, impacting on health care utilization and increasing medical costs. The review protocol is clearly written and well-structured.
In order to further improve the quality of the paper, the authors should address the following comments:
Search strategy and selection of studies -Search strategy: the authors should specify the specific search string they intended to use. When they make the search, the authors should be able to give a specific date when the search was conducted, not a week as is currently stated (3.-10. July).
-Related to the above mentioned point: do the authors have expertise to conduct a search or are the authors planning to involve an information specialist, e.g. an experienced librarian? In order to define and validate the search string, and to remove duplicates from the different electronic databases I would strongly advise you to consider this. -I would suggest to make the title and abstract screening in one stage, and then in a second stage for the full-texts. Potential moderators of between-group difference -The authors are planning to include depression as a potential moderator in their analyses. Specifically, authors are planning to include the "percentage of patients with depressive disorders" as a moderator variable. I see the potential problem that some studies will not report on depression, or will not explicitly state the percentage that you are looking for. Please state how you are going to include these publications. -Apart from depression, there may be other -even more important -parameters that may affect the effect sizes on health-related quality of life. Severity of LSS as measured with disability and pain scales, comorbidities, age will also play a role. Except for age, these confounders will not be accounted for through matching. The depression's moderating effect that you aim to quantify may be actually confounded by a set of other variables. -There is no detailed description of the methods you are planning to use for estimating the moderating effect of depression, reported in patient and control groups. -In Table 3 you state that you are going to report mean and standard deviation for age. How will you include publications not reporting age, or reporting median and interquartile ranges or ranges instead?
Outcomes -You describe that health related quality of life (QoL) will be either self-reported or interview based. Are you planning any subgroup analyses? -Why are you not considering the EQ-5D scale for measuring quality of life? -Please state how you are going to address the problem that multiple publications about the same cohort of LSS patients and controls may exist. Which one are you planning to include in the meta-analysis? Are you planning to include case series? -Will you exclude any study from the meta-analysis because of low methodological quality? Section: Meta-analytic procedure Summary measures -Please replace "random effect meta-analysis" by "random effects meta-analysis" throughout. -Please revise the sentence "For all the analyses, the p-value will be set at 0.05." I would advise not to pre-specify a level of significance but rather quantify the evidence on a continuous scale.
-You describe the categories of Cohen's effect sizes, >= 0.8, 0.5-0.8, and <=0.2. What about the missing level from 0.2-0.5 -did you mean that this represents "low" effect size? -Will you need a minimum number of studies for pooling or for being able to quantify the moderating effect of depression? Publication bias -Please describe that the trim-and-fill method will result in a new summary estimate. Are you planning to report the new summary estimate (after trim-and-fill) together with the original estimate in every meta-analysis? Please also report on the number of studies "filled". Moderator coding and analysis -You state that "if inconsistency between effect sizes is found" depression will be investigated as moderator. In fact, you should evaluate the moderating effect in all meta-analyses (if enough studies can be retrieved). Perhaps you want to describe pre-planned subgroup analyses in those studies with i) 100% patients with depression and ii) 0% patients with depression. How will you disentangle depression effects and LSS effects in studies where healthy controls did not show depressive disorders? -You are not defining any information on depression as inclusion criterion. Please describe how this will impact on the results. Please revise the conclusion of your abstract and discussion section accordingly. The rationale of the review and meta-analysis is given. The methods described in the article appear very sound; the analysis is registered and quality and risk of bias of each included study is assessed.
I congratulate the authors to their well-planned research and wish them luck that they will be able to include a satisfactory number of high-quality studies in order to obtain meaningful results. Response:
We warmly thank the Reviewer for this positive feedback and for the precious encouragement. The review protocol is clearly written and well-structured.
Response: We thank the Reviewer for having read carefully our paper and for being interested in our work. We have revised the manuscript trying to follow as much as possible all these constructive comments.
Search strategy and selection of studies -Search strategy: the authors should specify the specific search string they intended to use.
When they make the search, the authors should be able to give a specific date when the search was conducted, not a week as is currently stated (3.-10. July). Response: As requested, a specific date when the search will be conducted is given. Please, see revised "Information sources and search procedure" paragraph.
-Related to the above mentioned point: do the authors have expertise to conduct a search or are the authors planning to involve an information specialist, e.g. an experienced librarian? In order to define and validate the search string, and to remove duplicates from the different electronic databases I would strongly advise you to consider this. Response: We thank the Reviewer for this advice. We have followed it and planned that an experienced librarian will conduct the search, particularly in validating the search string across different electronic databases. Please, see revised "Information sources and search procedure" paragraph.
-I would suggest to make the title and abstract screening in one stage, and then in a second stage for the full-texts. We have followed the Reviewer's suggestion. Please, see revised "Selection of studies" paragraph. -Apart from depression, there may be other -even more important -parameters that may affect the effect sizes on health-related quality of life. Severity of LSS as measured with disability and pain scales, comorbidities, age will also play a role. Except for age, these confounders will not be accounted for through matching. The depression's moderating effect that you aim to quantify may be actually confounded by a set of other variables. Response: We thank the Reviewer for providing us with this important comment. As suggested, we have included additional moderators to be investigated. Please, see the added statements in "Rationale and objectives of the present protocol" and in "Subgroup and moderator analyses" paragraphs.
-There is no detailed description of the methods you are planning to use for estimating the moderating effect of depression, reported in patient and control groups. Response: We thank the Reviewer for this comment. We have added a statement which specifies the statistical methods planned to be used for estimating the moderating effects of all the moderators. Please, see revised "Subgroup and moderator analyses" paragraph as follows: "The relationship between the effect sizes and all these moderators will be investigated by conducting weighted least squares metaregression analyses.". Table 3 you state that you are going to report mean and standard deviation for age. How will you include publications not reporting age, or reporting median and interquartile ranges or ranges instead? Response: We thank the Reviewer for this precious comment. We have specified how mean age and standard deviation will be obtained if the paper does report them or report median and interquartile ranges. Please, see the changes added in Table 3 where coding of age is provided, as follows: "If the study does not report these data, they will be requested from the corresponding author. If this is not the case, mean and standard deviation will be estimated from median and interquartile ranges through the formula proposed by Wan and colleagues [43] . Otherwise, the study will be excluded from the analyses involving data on age.". In addition, the fact that some studies will not report the data for moderator coding or the authors are not available to provide them has been highlighted as a potential limitation in the "Strengths and limitations of the study" bullet points and in the "Discussion" section. Wood [42] .". We have decide to exclude case series because data in this type of publications are not suitable for our planned methods of meta-analysis. A statement regarding this point has been added in the "Eligibility criteria" paragraph.
-In

Outcomes
-Will you exclude any study from the meta-analysis because of low methodological quality? Response: We have specified more thoroughly how the findings of the quality assessment will be used. In particular, since the NOS does not provide a cut-off score to allow us to exclude studies with poor quality and restrict the analysis on the high-quality ones, we have followed the Reviewer's comment and we have chosen to investigate the association between study quality and effect sizes through a moderator analysis where the scores on the NOS are included as moderators.
Please, see revised "Subgroup and moderator analyses" paragraph.
Section: Meta-analytic procedure Summary measures -Please replace "random effect meta-analysis" by "random effects meta-analysis" throughout. Response: We have corrected it.
-Please revise the sentence "For all the analyses, the p-value will be set at 0.05." I would advise not to pre-specify a level of significance but rather quantify the evidence on a continuous scale. Response: We thank the Reviewer for this comment. As suggested, we have quantified the evidence on a continuous scale. Please, see the change in revised "Summary measures" paragraph. -Will you need a minimum number of studies for pooling or for being able to quantify the moderating effect of depression? Response: We thank the Reviewer for this comment. We have added a statement specifying the minimum number of studies for pooling or quantifying the moderating effects. Please, see the revisions in "Subgroup and moderator analyses" paragraph, as follows: "According to Valentine et al.'s recommendations [53] , the minimum number of studies for pooling the data and performing effect size calculation will be 2. Following the guidelines for a continuous study level variable proposed by Fu et al. [54] , at least 6 to 10 studies will be necessary to investigate the moderating effects through meta-regression.". Moderator coding and analysis -You state that "if inconsistency between effect sizes is found" depression will be investigated as moderator. In fact, you should evaluate the moderating effect in all metaanalyses (if enough studies can be retrieved). Perhaps you want to describe pre-planned subgroup analyses in those studies with i) 100% patients with depression and ii) 0% patients with depression. How will you disentangle depression effects and LSS effects in studies where healthy controls did not show depressive disorders? Response: We thank the Reviewer for this relevant comment. The reviewer points out an important problem and a potential limitation of our review. We expect that it is quite unlikely to find studies with 100% and 0% patients with depressive disorders (and also 100% controls with depressive disorders). With regard to the second aspect, we think that we might disentangle depression effects and LSS effects in studies with controls without depressive disorders by adding the percentage of controls with depressive disorders in the moderator analysis model. This strategy can allow us to include the studies with any percentages of depressive disorders in the control groups. If studies where healthy controls without depressive disorders are retrieved, we will include the percentage of healthy controls with depressive disorders (range = 0-100%) as moderator in the multivariate meta-regression model to examine whether the percentage of controls with depression moderate the effect sizes. We can
